3017 NSCLC with high PD-L1 expression on tumor cells or tumorinfiltrating immune cells represents distinct cancer subtypes. (September 2015) - Schmid, P.; Kowanetz, M.; Koeppen, H.; Zou, W.; Wistuba, I.; Kockx, M.; Kadel, E.E.; Chaft, J.; Rizvi, N.A.; Hirsch, F.R.; Smith, D.; Miley, N.; et al.